Prodrugs for Improved Drug Delivery: Lessons Learned from Recently Developed and Marketed Products
Prodrugs are bioreversible, inactive drug derivatives, which have the ability to convert into a parent drug in the body. In the past, prodrugs were used as a last option; however, nowadays, prodrugs are considered already in the early stages of drug development. Optimal prodrug needs to have effecti...
Saved in:
Main Authors: | Milica Markovic (Author), Shimon Ben-Shabat (Author), Arik Dahan (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Phospholipid-Based Prodrugs for Colon-Targeted Drug Delivery: Experimental Study and In-Silico Simulations
by: Milica Markovic, et al.
Published: (2019) -
Prospects and Challenges of Phospholipid-Based Prodrugs
by: Milica Markovic, et al.
Published: (2018) -
PLA<sub>2</sub>-Triggered Activation of Cyclosporine-Phospholipid Prodrug as a Drug Targeting Approach in Inflammatory Bowel Disease Therapy
by: Milica Markovic, et al.
Published: (2022) -
Segmental-Dependent Solubility and Permeability as Key Factors Guiding Controlled Release Drug Product Development
by: Milica Markovic, et al.
Published: (2020) -
BCS Class IV Oral Drugs and Absorption Windows: Regional-Dependent Intestinal Permeability of Furosemide
by: Milica Markovic, et al.
Published: (2020)